17 employees
Prominex is focused on the development and manufacture of molecular diagnostic assays for Point-of-Care (POC) infectious disease testing.
2018
$4M
from 1 investors over 1 rounds
Prominex Inc. raised $4M on September 13, 2018
Investors: Casdin Capital, LLC